1.Research progress of human amniotic membrane applications.
Journal of Biomedical Engineering 2014;31(4):930-934
Application research on human amniotic membrane has been carried out for nearly a hundred years and people found that there were more than dozens of kinds bioactive substances in the amniotic membrane. It has been proved that the amniotic membrane has a lot of functions, such as anti-inflammatory, anti-bacterial, anti-virus, anti-angiogenic and promoting cell apoptosis, and soon. As effective treatments, amniotic membrane has been used for adjunctive therapy of burns, trauma, ophthalmic damage, dermatopathya. Recent advances of amniotic membrane and amniotic membrane-derived cells research have led to enormous progress in skin tissue engineering, vascular tis- sue engineering, biological scaffold material, and biological sustained-release materials. Amniotic membrane and amniotic membrane derived cells have a significant advantage and unique charm in medical field. Therefore, they have higher research value and broad prospects in the applications.
Amnion
;
Biomedical Research
;
trends
;
Humans
;
Tissue Engineering
;
Treatment Outcome
3. Effects of application of vancomycin in the early stage of patients with extremely severe burn
Zhu ZHU ; Guowen CAO ; Junjie BAO ; Zhanhong HU ; Zhu SHEN ; Hong TAO ; Bin CAO ; Feng XU
Chinese Journal of Burns 2017;33(4):206-210
Objective:
To evaluate the effects of application of vancomycin in the early stage of patients with extremely severe burn, in order to provide reference to drug for anti-infection treatment in the early stage of patients with extremely severe burn.
Methods:
Data of 15 patients of Kunshan explosion on August 2nd, 2014, admitted to the Department of Intensive Care in our hospital were retrospectively analyzed. The clinical efficacy of continuously intravenous dripping of vancomycin (combined with imipenem) in the early stage of burns (before and on post burn day 14) was analyzed. (1) The steady state plasma concentration of vancomycin was monitored respectively 30 min before the third, sixth, and tenth medication with direct chemiluminescent imaging method. (2) The distribution of Gram-positive bacteria of patients during hospitalization and their drug resistance to 14 antibiotics commonly used in clinic were analyzed. (3) Serum level of procalcitonin (PCT), white blood cell count, percentage of neutrophils before and after treatment, and efficacy grade of anti-infection treatment in the early stage of burns were analyzed. (4) Serum levels of aspartate transaminase (AST), alanine aminotransferase (ALT), creatinine before and after treatment, and the adverse effects during medication were analyzed. The WHONET 5.5 statistical software was used to analyze the distribution of Gram-positive bacteria in all the pathogens, and the status of drug resistance of Gram-positive bacteria to 14 antibiotics. Data were processed with Wilcoxon rank sum test.
Results:
(1) Twenty-nine times of steady state plasma concentration monitoring were performed in the patients in total, with the steady state plasma concentration of vancomycin from 4.3 to 42.1 μg/mL. In the monitoring before third, sixth, and tenth medication, the percentages of result reaching the standard were respectively 1, 3/14, and 2/7. (2) A total of 79 Gram-positive bacteria were isolated, including 49 (62.03%) strains of
4.Fluoroscopically Guided Three-Tube Insertion for the Treatment of Postoperative Gastroesophageal Anastomotic Leakage.
Guowen YIN ; Qingyu XU ; Shixi CHEN ; Xiangjun BAI ; Feng JIANG ; Qin ZHANG ; Lin XU ; Weidong XU
Korean Journal of Radiology 2012;13(2):182-188
OBJECTIVE: To retrospectively evaluate the feasibility and effectiveness of three-tube insertion for the treatment of postoperative gastroesophageal anastomotic leakage (GEAL). MATERIALS AND METHODS: From January 2007 to January 2011, 28 cases of postoperative GEAL after an esophagectomy with intrathoracic esophagogastric anastomotic procedures for esophageal and cardiac carcinoma were treated by the insertion of three tubes under fluoroscopic guidance. The three tubes consisted of a drainage tube through the leak, a nasogastric decompression tube, and a nasojejunum feeding tube. The study population consisted of 28 patients (18 males, 10 females) ranging in their ages from 36 to 72 years (mean: 59 years). We evaluated the feasibility of three-tube insertion to facilitate leakage site closure, and the patients' nutritional benefit by checking their serum albumin levels between pre- and post-enteral feeding via the feeding tube. RESULTS: The three tubes were successfully placed under fluoroscopic guidance in all twenty-eight patients (100%). The procedure times for the three tube insertion ranged from 30 to 70 minutes (mean time: 45 minutes). In 27 of 28 patients (96%), leakage site closure after three-tube insertion was achieved, while it was not attained in one patient who received stent implantation as a substitute. All patients showed good tolerance of the three-tube insertion in the nasal cavity. The mean time needed for leakage treatment was 21 +/- 3.5 days. The serum albumin level change was significant, increasing from pre-enteral feeding (2.5 +/- 0.40 g/dL) to post-enteral feeding (3.7 +/- 0.51 g/dL) via the feeding tube (p < 0.001). The duration of follow-up ranged from 7 to 60 months (mean: 28 months). CONCLUSION: Based on the results of this study, the insertion of three tubes under fluoroscopic guidance is safe, and also provides effective relief from postesophagectomy GEAL. Moreover, our findings suggest that three-tube insertion may be used as the primary procedure to treat postoperative GEAL.
Adult
;
Aged
;
Anastomosis, Surgical
;
Anastomotic Leak/radiography/*therapy
;
Decompression, Surgical/instrumentation
;
Drainage/instrumentation
;
Enteral Nutrition/instrumentation
;
Esophageal Neoplasms/*surgery
;
Esophagectomy
;
Female
;
Fluoroscopy
;
Humans
;
Intubation, Gastrointestinal/*methods
;
Male
;
Middle Aged
;
Postoperative Complications/*radiography/*therapy
;
Radiography, Interventional/*methods
;
Retrospective Studies
;
Stomach Neoplasms/*surgery
5.Influence of Cyclophosphamidum Used in Different Time during Menstrual Cycle on Ovary Anti-mullerian Hormone
Zhu SHEN ; Junjie BAO ; Ying ZENG ; Guowen CAO ; Aiming SHI ; Hong TAO ; Bin CAO ; Feng XU
China Pharmacist 2018;21(1):121-123
Objective:To preliminarily discuss the difference of ovary anti-miillerian hormone ( AMH) when cyclophosphamide is used in different time during menstrual cycle .Methods:Totally 30 young female patients with average age of (36 ±6.39) diagnosed as glomerular disease were treated with cyclophosphamide .According to the medication time , the patients were divided into follicular phase group and secretory phase group based on the property of menstrual cycle .Follicular phase group was treated with cyclophospha-mide during the first day and the eighth day of menstrual cycle .Secretory phase group was treated with cyclophosphamide after ovulato-ry time, namely the 14th day-the 16th day of menstrual cycle.AMH was detected before the drug treatment and 1st, 3rd, 6th and 10th cycles after cyclophosphamide treatment in the two groups .Results: AMH in the five periods had no statistic difference between the groups (P>0.05).There was significant difference in AMH before the treatment and after one-month treatment in the same group(P<0.05).AMH in different age groups showed statistic difference (P<0.05).Conclusion:There is no significant difference in AMH when cyclophosphamide is administrated in different time of menstrual cycle .However , ovarian function is impaired just by low dose cyclophosphamide (0.8g) with the first administration and will be recovered slowly at least half a year after the drug withdrawal .
6.Determination of sodium valproate and vancomycin in human serum by HPLC-MS/MS
Jingjing DUAN ; Guowen JI ; Zhijun GUO ; Feng XU
Journal of Pharmaceutical Practice 2022;40(4):350-353
Objective To establish a high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) method for simultaneous determination of sodium valproate and vancomycin in human serum. Methods Valproic acid-d6 and kanamycin B were used as the internal standard of sodium valproate and vancomycin, the serum samples were treated by acetonitrile precipitation protein method. The mobile phase was 0.1% formic acid aqueous solution-acetonitrile for gradient elution. The flow rate was 0.5 ml/min, with column temperature at 25 ℃. The sample volume was 4 μl and total analysis time was 12 min. The positive and negative ion mode was monitored by electrospray ion source and the multiple reaction monitoring mode was used for quantitative analysis. The specificity, standard curve, lower limit of quantification, precision, recovery, matrix effect, and stability of the method were examined. Results Sodium valproate and vancomycin had good linear relationships in the range of 1 - 200 μg/ml and 0.5 - 100 μg/ml, respectively. The quantitative lower limits were 1 μg/ml and 0.5 μg/ml, respectively. The extraction recoveries were above 70%. The inter- and intra-batch precision RSD values were less than 10%. The stability was good and there was no obvious matrix effect. Conclusion This method is simple, quick, sensitive, specific and accurate, which could be used to simultaneously determine the concentration of sodium valproate and vancomycin in human serum.
7.Efficacy and safety of ceftazidime and avibactam sodium in the treatment of carbapenem-resistant organism infection
Jiaojiao MAO ; Guowen CAO ; Zhu ZHU ; Hong TAO ; Feng XU
China Pharmacy 2023;34(16):1984-1988
OBJECTIVE To observe the efficacy and safety of ceftazidime and avibactam sodium (CAZ/AVI) in the treatment of carbapenem-resistant organism (CRO) infection. METHODS The information of patients with CRO infection admitted to the Second Affiliated Hospital of Soochow University from September 2019 to March 2022 was collected, and the patients were retrospectively divided into observation group (48 cases) and control group (48 cases) according to the treatment plan. The control group was given Polycolistin B sulfate for injection intravenously at a dose of 500 000 U every 12 hours; no dose adjustment was performed in patients with renal insufficiency or receiving continuous renal replacement therapy (CRRT). The observation group was given continuous micropump of CAZ/AVI for injection intravenously at a dose of 2.5 g every 8 hours for 2 continous hours; among them, the patients with renal insufficiency received an adjusted dose based on creatinine clearance, and no dose adjustment was performed in patients receiving CRRT. The clinical efficacy and microbiological efficacy as well as body temperature, white blood cell (WBC), C-reactive protein (CRP) and procalcitonin (PCT) before and after treatment were compared between 2 groups. The prognosis and the occurrence of adverse drug reactions were recorded. The factors influencing the clinical efficacy were screened by Logistic regression analysis. RESULTS The effective rate and microbial clearance rate of the observation group were significantly higher than the control group (P<0.05). After treatment, body temperature, PCT and CRP of 2 groups were significantly lower than before treatment, and CRP of the observation group was significantly lower than the control (No.SDFEYJLC2105) group (P<0.05). There was no statistically significant differencebetween the two groups in terms of rehabilitation discharge rate, the proportion of patients transferred to general wards,the proportion of dead patients, and the total incidence ofadverse drug reactions (P>0.05). CAZ/AVI and prolonging therapy duration were more likely to achieve clinical benefits (odds ratios of 1.146, 7.707,P<0.05), while lung infection and CRRT may be independent risk factors for treatment failure (odds ratios of 0.182, 0.236, P<0.05). CONCLUSIONS CAZ/AVI has good efficacy and safety in the treatment of CRO infection, the appropriate extension of antibacterial treatment time can achieve a higher clinical response rate, while lung infection or CRRT may lead to treatment failure.
8.Clinical and imaging features of eight cases of Ewing sarcoma of the jaw.
Yinglian FENG ; Tiemei WANG ; Zitong LIN ; Lei ZHANG ; Xiaofeng HUANG ; Guowen SUN ; Shu XIA
West China Journal of Stomatology 2023;41(2):185-189
OBJECTIVES:
This study investigate the clinical and imaging features of Ewing sarcoma (ES) of the jaw.
METHODS:
Eight cases of pathologically diagnosed ES of the jaw from January 2010 to June 2022 were included in the study. Clinical and radiological features were retrospectively analyzed.
RESULTS:
Among the eight cases, the mean age at onset was 29.4 years, and the male to female ratio was 7∶1. The predilecting site was the posterior part of mandible, accounting for 75% of the cases. The lesions often exhibited early numbness of the lower lip and lymphadenopathy. The main radiographic manifestation of mandibular lesions was ill-defined radiolucency, mixed with fibrous or brush-like tumor matrix, and soft tissue mass. The maxillary ES lesions mainly presented as lytic bone destruction accompanied by adjacent soft tissue mass. Periosteal ossification was rarely seen.
CONCLUSIONS
The clinical and imaging characteristics of ES in the jaw are helpful for its diagnosis.
Male
;
Humans
;
Female
;
Sarcoma, Ewing/pathology*
;
Retrospective Studies
;
Radiography
;
Mandible/pathology*
;
Lip
;
Bone Neoplasms